-
Major Development From Biotech Stocks On News: Sarepta Therapeutics, GlaxoSmithKline, Prosensa, BioCryst, Inovio, Sequenom, Lilly, Transition Therapeutics, Illumina, Omnicare, PDL BioPharma, Questcor
Sarepta Therapeutics Inc (NASDAQ:SRPT) dropped around 19% that was the most in 14 months on investor concerns that U.S. supervisory bodies won’t consider the firm’s treatment for Duchenne muscular dystrophy on an accelerated basis. The biotechnology firm declared that it aims to seek authorization of eteplirsen in the first half of 2013 following the Food…
-
Pharmaceutical Stocks In Hot List: Pfizer Inc. (NYSE:PFE), Eli Lilly & Co. (NYSE:LLY)
Big healthcare sector firms Pfizer Inc. (NYSE:PFE) and Eli Lilly & Co. (NYSE:LLY) are plans to post its fourth quarter results before the open on Tuesday, Jan 29, 2013 as both firms endure to manage their post-blockbuster decrease. According to the analysts polled by Thomson Reuters,anticipate Pfizer (PFE) to declared profit of 44 cents per…
-
December Jobs Data Helps Stocks With Gains, Tech Stocks Low, Apple Inc. (NASDAQ:AAPL) Slid 2.8 % & Citigroup Inc. (NYSE:C) Advanced 2.5 %
The healthy December jobs data had a gentle effect on the US stocks and sent the Standard and Poor’s 500 Index to the highest level since 2007. According to the jobs data employers added plenty jobs in December at the same pace of November. With the decline in the tech shares, Cupertino, California based Apple…
-
Citigroup, NYSE:C, JPMorgan Chase, NYSE:JPM, Wells Fargo, NYSE:WFC, Goldman Sachs NYSE:GS, C, JPM, WFC, GS,
Wall Street declined, sending the Dow industrials toward a fourth-straight daily decline and a second-straight triple-digit drop, as sluggish outlooks from energy, industrial, commodity heavyweights revisited concerns about a global economic slump. Facebook Inc. (NASDAQ:FB) paid £238,000 as corporate tax over last year’s estimated revenues of £175 million, according to social media giant’s accounts filed…
-
Facebook Inc (NASDAQ:FB) on its Way to Launch a Native Android Application – (AA, SIRI, ZNGA, LLY)
U.S. investors seemed careful before the opening of the third-quarter earnings season, which begins in earnest this week with Alcoa Inc. (NYSE:AA)’s corporate results today. For the first time in 11 quarters, Wall Street anticipate S&P 500 companies to report a year-over-year earnings fall. The Organization for Economic Cooperation and Development’s leading indicators of economic…
-
The Best Sector For Investments When Markets Are Moving South – (PFE, BSX, MRX, LLY)
The healthcare sector is considered one of the best spots for investments when markets are moving south. The demand for such services generally continues to show no change even during an economic slump and investments in the sector helps investors seeking sufficient protection to the capital invested. A number of pharmaceutical companies also declare regular…
-
Major Pharma Companies Sustain Revenue Growth In Promising Markets – (PFE, LLY, BMY, JNJ)
Major pharma companies across the universe such as Pfizer Inc. (NYSE:PFE) and recent top price hitter Eli Lilly & Co. (NYSE:LLY) continue to generate higher revenue from sales in promising market countries. For Pfizer, rising market sales moved up in the second quarter of fiscal 2012 to $2.6 billion. Over the similar quarter, Eli Lily…
-
S&P 500 Recovers; Both Sprint Nextel Corporation (NYSE:S) And Microsoft Corporation (NASDAQ:MSFT) Gains
U.S. stocks opened lower but recovered, with the S&P 500 index (INDEXSP:.INX) now up 0.1% after Commerce Department released seasonally adjusted data on durable goods orders, with percent changes as compared to prior months. Overall U.S. durable goods orders moved up a seasonally adjusted 4.2 percent in July but without aircraft and other transportation goods,…
-
Weak New Products Sales Is Not The Only Factor Hurting The Pharmaceutical Industry – (PFE, BMY, MRK, LLY, JNJ)
In the pharmaceutical industry, Generic rivalry and scarce new product sales are not the only factors slowing performance in the current year. More challenges include EU and Japan pricing pressure as well as depressing currency trend. In fact, corporate earnings of several industry players including Johnson & Johnson (NYSE:JNJ) were hit by negative currency movement…
-
A New Study Reveals Off Label Use Of Powerful Antipsychotic Medications – (PFE, LLY, JNJ)
A new study reveals that use of powerful antipsychotic medications including Abilify and Risperdal which are used to control youngsters with attention-deficit/hyperactivity disorder (ADHD) and other behavior issues has jumped in recent years. Antipsychotics are approved to be used for the treatment of bipolar disorder, schizophrenia, other serious mental problems and irritability concerning autism. But…